banner investors 1920x462

Company Profile

CURE Pharmaceutical® is a vertically integrated drug delivery and development company committed to improving drug efficacy, safety, and the patient experience through its proprietary drug dosage forms and delivery systems. CURE has a cGMP manufacturing facility and is a pioneering developer and manufacturer of a patented and proprietary oral delivery platform, called CUREform™, which includes CUREfilm®, one of the most advanced oral thin films on the market today and CUREpods™ a novel chewable delivery system. CUREform's combined technologies provide opportunities for both immediate and controlled-release drug delivery of a wide range of active ingredients. CURE partners with biotech, pharmaceutical and wellness companies worldwide and has positioned itself to advance numerous therapeutic categories, including the pharmaceutical cannabis sector with partnerships in the U.S., Canada, Israel, and other markets. The company’s mission is to improve people’s lives by redefining how medicines are delivered and experienced.

Cure Pharmaceutical Corporation was founded in July 2011 and is a wholly-owned subsidiary of Cure Pharmaceutical Holding Corp, a public company.

Cure Pharmaceutical Investor Presentation

Download Our Investor Presentation

 
 
 

Stock Price: Today

Past Six Months

Key Contacts

Investor Relations

INVESTOR RELATIONS:
Liviakis Financial Communications
655 Redwood Hwy., Suite 395
Mill Valley, CA 94942
Phone: (415) 389-04670
Fax: (415) 389-4694

Transfer Agent

VStock Transfer, LLC
18 Lafayette Place
Woodmere, NY 11598
Phone: (212) 828-8436
Facsimile: (646) 536-3179
www.VStockTransfer.com

Auditors

RBSM, LLP
805 3rd Ave., #1430
New York, NY 10022
(917) 229-4610

Corporate Counsel

Carmel, Milazzo & DiChiara, LLP
55 West 39th Street, 18th Floor Penthouse
New York, New York 10018
(212) 658-0458